Jan 7 (Reuters) - Dimerix Ltd DXB.AX :
* SAFETY REVIEW COMMITTEE OVERSEEING CO'S TWO PHASE 2 STUDIES AFFIRMED POSITIVE RECOMMENDATION THAT BOTH TRIALS CONTINUE WITHOUT MODIFICATION
* AN INDEPENDENT SAFETY REVIEW COMMITTEE DID NOT IDENTIFY ANY SAFETY CONCERNS IN PATIENTS ADMINISTERED DMX-200